74319-96-3 Usage
Description
3,4-Dimethyl-5-nitro-benzoic acid is a yellow crystalline powder with the chemical formula C9H9NO4. It is a versatile chemical compound known for its nitro and carboxylic acid groups, making it useful in the development of drugs and other pharmaceutical products.
Uses
Used in Pharmaceutical Industry:
3,4-Dimethyl-5-nitro-benzoic acid is used as an intermediate in the synthesis of various organic compounds for the development of drugs and pharmaceutical products.
Used in Antimicrobial Applications:
3,4-Dimethyl-5-nitro-benzoic acid is studied for its potential antimicrobial properties, making it a promising candidate for research and development in the field of microbiology.
Used in Antioxidant Applications:
3,4-Dimethyl-5-nitro-benzoic acid is also studied for its potential antioxidant properties, which can be beneficial in various fields of research and development, including pharmaceuticals and cosmetics.
Check Digit Verification of cas no
The CAS Registry Mumber 74319-96-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,3,1 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 74319-96:
(7*7)+(6*4)+(5*3)+(4*1)+(3*9)+(2*9)+(1*6)=143
143 % 10 = 3
So 74319-96-3 is a valid CAS Registry Number.
74319-96-3Relevant articles and documents
An improved synthesis of 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
Atwell, Graham J,Yang, Shangjin,Denny, William A
, p. 825 - 828 (2007/10/03)
5,6-Dimethylxanthenone-4-acetic acid (DMXAA) is a novel anticancer agent with a number of unique activities, and is in clinical trial. The current synthesis of DMXAA involves six steps, beginning with a heterogeneous reaction to form an isonitrosoacetanilide, and gives an overall yield of 11% from 2,3-dimethylaniline. We report an alternative synthesis of the key intermediate 3,4-dimethylanthranilic acid via nitration of 3,4-dimethylbenzoic acid and separation of the key desired isomer by ready crystallisation. This, together with improvements in the rest of the synthesis, provide a shorter and higher-yielding route to DMXAA (22% overall from 3,4-dimethylbenzoic acid).